Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kokan, Jalal
ATNEC, NCT04109079: Axillary Management in Breast Cancer Patients with Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy	Recruiting	N/A	1900	Europe	Axillary lymph node dissection, Axillary radiotherapy, Breast or chest wall radiotherapy	University Hospitals of Derby and Burton NHS Foundation Trust	Breast Cancer, Sentinel Lymph Node, Neoplasm, Breast	02/30	02/30
Pettit, Laura
CompARE, NCT04116047 / 2014-003389-26: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)	Active, not recruiting	3	785	Europe	Cisplatin, CDDP, Platinol, Durvalumab, MEDI-4736, Imfinzi, Radiotherapy	University of Birmingham, AstraZeneca, Cancer Trials Ireland	Oropharyngeal Cancer	12/26	12/30
POETIC-A, NCT04584853 / 2019-003897-24: PreOperative Endocrine Therapy for Individualised Care With Abemaciclib	Recruiting	3	2032	Europe	Abemaciclib, Verzenios, Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen), Arimidex, Aromasin, Femara, or Tamoxifen	Institute of Cancer Research, United Kingdom	Breast Cancer Female	09/30	03/32
ATNEC, NCT04109079: Axillary Management in Breast Cancer Patients with Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy	Recruiting	N/A	1900	Europe	Axillary lymph node dissection, Axillary radiotherapy, Breast or chest wall radiotherapy	University Hospitals of Derby and Burton NHS Foundation Trust	Breast Cancer, Sentinel Lymph Node, Neoplasm, Breast	02/30	02/30